Resveratrol as an adjunct to resuscitation fluid following hemorrhage injury
白藜芦醇作为失血性损伤后复苏液的辅助剂
基本信息
- 批准号:8397416
- 负责人:
- 金额:$ 27.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsAttenuatedCardiacCell SurvivalCellsCessation of lifeChIP-on-chipControl AnimalDataDietary ComponentDoseDown-RegulationEnhancersEnzymesFree RadicalsFunctional disorderGenesGoalsGrapesHealthHeartHemorrhageHemorrhagic ShockHomologous GeneHourHypoxiaIn VitroInjuryIntestinesIschemiaKnowledgeLeftLeft Ventricular FunctionLiquid substanceLiverLongevityMating TypesMediatingMediator of activation proteinMethodsMitochondriaModelingMolecularMorbidity - disease rateNF-kappa BOrganOutcomeOxidative PhosphorylationPathway interactionsPerformancePerfusionPlantsProtein AcetylationRattusRegulationReperfusion InjuryReperfusion TherapyResolutionResuscitationResveratrolTechniquesTestingTherapeuticTimeTissuesTraumaVentricularWorkYeastsbasec-myc Genescell injurycytochrome ccytokineenzyme activityfunctional genomicsheme oxygenase-1improvedin vitro Modelin vivoinhibitor/antagonistmortalitynoveloxidative damagephytoalexinphytoalexinspolyphenolresearch studytooltrans-resveratrol
项目摘要
DESCRIPTION (provided by applicant): Severe hemorrhage causes whole body hypoxia, multiple organ dysfunction and death. Fluid resuscitation is employed to restore organ perfusion and reoxygenation following hemorrhagic injury. Reoxygenation causes oxidative damage and cell and organ injury and there is a need to develop better resuscitation methods to reduce cell injury following hemorrhage. Our systematic study of mitochondrial functional genomics in the rat resulted in the identification of a novel pathway involving Sirt1 (mammalian homolog of sir2-silent mating type information regulation 2) in hemorrhagic injury. Our studies demonstrated a significant decline in Sirt1 expression following trauma-hemorrhage (T- H). Our preliminary data also indicate that resveratrol (trans-3,5,4'-trihydroxystilbene), a phytoalexin antioxidant found i grapes, and an enhancer of Sirt1 activity, reduces heart and liver injury following hemorrhage. Our objective is therefore to establish that resveratrol can be used as an adjunct to resuscitation
fluid, following hemorrhage. We will also determine the molecular basis of tissue injury and resveratrol-mediated protection following T-H. Our hypothesis is that resveratrol reduces organ injury following hemorrhagic shock and therefore it can be used as an adjunct to resuscitation fluid. We will test the central hypothesis by pursuing the following four Specific Aims: (1) optimize the time and dose of resveratrol as an adjunct to resuscitation fluid, (2) establish that resveratrol improves survival and reduces organ injury following T-H. (3) determine the effect of resveratrol treatment on cellular energetics following T-H in the heart and the liver, and (4) identify the mediators and mechanism of T-H injury resolution by resveratrol using in vivo and in vitro models. We will use state-of-the-art tools and techniques such as mitochondrial functional genomics and ChIP-chip method to test the hypothesis. When the proposed studies are completed, in addition to identifying resveratrol as an adjunct to resuscitation fluid, we would have also gained new knowledge on molecular pathways involved in hemorrhage injury and their modulation by the antioxidant resveratrol. PUBLIC HEALTH RELEVANCE: T-H injury is a significant health burden as it accounts for up to 40% of trauma-related deaths. Our long-term goal is to develop better therapeutic methods to reduce morbidity and mortality following trauma-hemorrhagic shock.
PUBLIC HEALTH RELEVANCE: Hemorrhage accounts for almost half of trauma-related deaths in the United States. Following hemorrhage, fluid resuscitation is employed to restore organ perfusion and reoxygenation. Reoxygenation causes oxidative damage and cell injury. Our objective is to develop better resuscitation methods to reduce tissue damage following hemorrhage. Based upon our preliminary data, we propose that resveratrol, when used as an adjunct to resuscitation fluid, will reduce cell injury following hemorrhage.
描述(由申请人提供):严重的出血会导致全身缺氧,多器官功能障碍和死亡。流体复苏用于恢复出血性损伤后的器官灌注和重氧。重氧会导致氧化损伤,细胞和器官损伤,并且有必要开发出更好的复苏方法来减少出血后细胞损伤。我们对大鼠线粒体功能基因组学的系统研究导致鉴定出涉及SIRT1的新途径(siR2-SiR2-SiLent交配类型信息调节2)中的新途径。我们的研究表明,创伤性突出(T- H)后SIRT1表达显着下降。我们的初步数据还表明,白藜芦醇(Trans-3,5,4'-Trihydroxystilbene),一种植物甲状腺素抗氧化剂发现了I葡萄和SIRT1活性的增强剂,可减少出血后心脏和肝损伤。因此,我们的目标是确定白藜芦醇可以用作复苏的辅助
流体,出血后。我们还将确定T-H后组织损伤和白藜芦醇介导的保护的分子基础。我们的假设是,白藜芦醇在出血性休克后减少器官损伤,因此可以用作复苏液的辅助。我们将通过追求以下四个特定目的来检验中心假设:(1)优化白藜芦醇作为复苏液的辅助的时间和剂量,(2)确定白藜芦醇可改善生存率并减少T-H后的器官损伤。 (3)确定白藜芦醇处理对心脏和肝脏T-H之后细胞能量的影响,(4)(4)通过使用体内和体外模型来确定白藜芦醇通过白藜芦醇解决T-H损伤的介体和机制。我们将使用最先进的工具和技术,例如线粒体功能基因组学和芯片芯片方法来检验假设。当提出的研究完成后,除了确定白藜芦醇作为复苏液的辅助外,我们还将获得有关与出血损伤有关的分子途径以及抗氧化剂白藜芦醇调节的新知识。公共卫生相关性:T-H受伤是一种重大健康负担,因为它占与创伤有关的死亡的40%。我们的长期目标是开发更好的治疗方法,以降低创伤性造成伤害性休克后的发病率和死亡率。
公共卫生相关性:在美国,出血占与创伤有关的死亡的一半。出血后,采用液体复苏来恢复器官灌注和重氧。重氧会导致氧化损伤和细胞损伤。我们的目标是开发更好的复苏方法,以减少出血后的组织损伤。根据我们的初步数据,我们建议白藜芦醇用作复苏液的辅助,将减少出血后细胞损伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raghavan Pillai Raju其他文献
Raghavan Pillai Raju的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raghavan Pillai Raju', 18)}}的其他基金
Reparative effect of juvenile factors in aging and injury
幼年因素对衰老和损伤的修复作用
- 批准号:
10642834 - 财政年份:2022
- 资助金额:
$ 27.84万 - 项目类别:
Reparative effect of juvenile factors in aging and injury
幼年因素对衰老和损伤的修复作用
- 批准号:
10444135 - 财政年份:2022
- 资助金额:
$ 27.84万 - 项目类别:
Reparative effect of juvenile factors in aging and injury
幼年因素对衰老和损伤的修复作用
- 批准号:
10445560 - 财政年份:2021
- 资助金额:
$ 27.84万 - 项目类别:
Resveratrol as an adjunct to resuscitation fluid following hemorrhage injury
白藜芦醇作为失血性损伤后复苏液的辅助剂
- 批准号:
8825553 - 财政年份:2012
- 资助金额:
$ 27.84万 - 项目类别:
Resveratrol as an adjunct to resuscitation fluid following hemorrhage injury
白藜芦醇作为失血性损伤后复苏液的辅助剂
- 批准号:
8517149 - 财政年份:2012
- 资助金额:
$ 27.84万 - 项目类别:
Resveratrol as an adjunct to resuscitation fluid following hemorrhage injury
白藜芦醇作为失血性损伤后复苏液的辅助剂
- 批准号:
8703133 - 财政年份:2012
- 资助金额:
$ 27.84万 - 项目类别:
INFLUENCE OF AGING ON MITOCHONDRIAL GENE EXPRESSION FOLLOWING TRAUMA-HEMORRHAGE
衰老对创伤出血后线粒体基因表达的影响
- 批准号:
7586835 - 财政年份:2008
- 资助金额:
$ 27.84万 - 项目类别:
INFLUENCE OF AGING ON MITOCHONDRIAL GENE EXPRESSION FOLLOWING TRAUMA-HEMORRHAGE
衰老对创伤出血后线粒体基因表达的影响
- 批准号:
7470522 - 财政年份:2008
- 资助金额:
$ 27.84万 - 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 27.84万 - 项目类别:
Targeting TLR4-lipid rafts to prevent postoperative pain
靶向 TLR4 脂筏预防术后疼痛
- 批准号:
10701528 - 财政年份:2023
- 资助金额:
$ 27.84万 - 项目类别:
Development of a Neutrophil Degranulation Inhibitor to Treat ARDS
开发治疗 ARDS 的中性粒细胞脱颗粒抑制剂
- 批准号:
10697442 - 财政年份:2023
- 资助金额:
$ 27.84万 - 项目类别: